Nowadays, current clinical techniques usually involve sampling by specialized personnel, transport of the sample to a laboratory, and the use of time-consuming processes which delay the diagnosis for several days and hinder the evaluation of a disease in big groups. The still on-going COVID-19 crisis is showing the need for cost-effective, real-time and user-friendly detection methods, able to provide a fast diagnosis which would improve the patient prognosis and disease prevention. In this EPIC Online Technology Meeting, we are going to present different alternatives and European capabilities for the development of Photonic Integrated Circuits biosensors for virus detection including chip design, fabrication, packaging and biofunctionalization of the sensor surface.
The webinar is supported by the PIXAPP Pilot Line* and Pix4Life**.
* The PIXAPP Pilot Line has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 731954.
** Pix4Life has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643995.
Ana Gonzalez, R&D Manager, EPIC – European Photonics Industry Consortium
16:00 – 16:05 Welcoming words – Ana Gonzalez, R&D Manager, EPIC – European Photonics Industry Consortium
16:05 – 16:25 Inigo Artundo, CEO, VLC Photonics (SPAIN)
16:25 – 16:45 Arne Leinse, CEO, LioniX International (THE NETHERLANDS)
16:45 – 17:05 Padraic Morrissey, Technology Manager, PIXAPP Pilot Line & Research Manager, Tyndall National Institute (IRELAND)
17:05 – 17:30 Discussion moderated by Ana Gonzalez, R&D Manager, EPIC – European Photonics Industry Consortium